SCHEMBL23646244

SCHEMBL23646244

O=C(O)CCCCCCCCCCCCNC(=O)N1CCOCC1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.62
PRMT1 Q99873 1/20 0.50
ITGB3 P05106 1/20 0.48
ITGA2B P08514 1/20 0.48
ADRA1A P35348 2/20 0.47
KMT2A Q03164 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.46
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
DRD2 P14416 2/20 0.43
DRD3 P35462 2/20 0.43
NAMPT P43490 2/20 0.43
MAPK1 P28482 1/20 0.42
PAOX Q6QHF9 1/20 0.42
GLA P06280 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23646278 1.00 HTT (0.62) HTTPRMT1ITGB3ITGA2BADRA1A
SCHEMBL23646274 1.00 HTT (0.62) HTTPRMT1ITGB3ITGA2BADRA1A
SCHEMBL23646233 1.00 HTT (0.62) HTTPRMT1ITGB3ITGA2BADRA1A
SCHEMBL6467994 0.86 HTT (0.60) HTTITGB3ITGA2BKMT2ASMN1; SMN2
SCHEMBL8396561 0.82 HTT (0.84) HTTKMT2ASMN1; SMN2MEN1ALDH1A1
SCHEMBL5694307 0.82 HTT (0.84) HTTKMT2ASMN1; SMN2MEN1ALDH1A1
SCHEMBL8394887 0.82 HTT (0.84) HTTKMT2ASMN1; SMN2MEN1ALDH1A1
SCHEMBL9659457 0.82 HTT (0.84) HTTKMT2ASMN1; SMN2MEN1ALDH1A1
SCHEMBL4801343 0.80 HTT (0.66) HTTADRA1AKMT2ASMN1; SMN2MEN1
SCHEMBL1753844 0.80 HTT (0.87) HTTADRA1AKMT2ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12258324-B2 Fatty acid analogues and methods of use LIN BIOSCIENCE INC. (TW) 2025-03-25 US disclosed
US-20210221781-A1 FATTY ACID ANALOGUES AND METHODS OF USE LIN BIOSCIENCE INC. (TW) 2021-07-22 US disclosed
US-20210221781-A1 FATTY ACID ANALOGUES AND METHODS OF USE LIN BIOSCIENCE INC. (TW) 2021-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210221781-A1 FATTY ACID ANALOGUES AND METHODS OF USE ELOVL1, FADS1, ALOX5 HTT 3131/4885PRMT1 4275/4885ITGB3 2789/4885
US-12258324-B2 Fatty acid analogues and methods of use ELOVL1, FADS1, ALOX5 HTT 3131/4885PRMT1 4275/4885ITGB3 2789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.